Social Media : Lung Institute has multiple social media pages including: Facebook, Twitter, Google+, YouTube and Pinterest. Lung Institute social media pages are managed by Lung Institute staff members who post news and other items of interest to be consumed by the public. If you have a social media account, you can log in to your account to post comments, and 'like' or ‘follow’ Lung Institute social media pages and individual entries. If once you click on a lung Institute social media page, you comment or click on the 'like' button, your Protected Identifiable Information (PII) will be visible to Lung Institute staff and other social media site visitors. The amount of visible personal information displayed will depend on your own Social Media privacy settings. You can completely avoid displaying any PII by not creating a Social Media account, not posting comments, not clicking on the 'like' or ‘follow’ options, or interacting with Lung Institute Social Media accounts in any way (., private messaging, sharing Lung Institute posts, etc.). Lung Institute staff does not collect, use or disclose any information about visitors who comment, 'like' or ‘follow’ the Lung Institute Social Media sites. However, as a practice, comment moderator policy requires the removal from Lung Institute Social Media pages of any comments that contain spam or are improper, inflammatory, or offensive. The information is then saved on a password-protected shared drive accessible to Lung Institute Managers, System Owners, Communications Staff, Web Teams, and other designated staff who require this information to perform their duties.
Oxygen therapy is frequently provided along with pharmacological interventions to treat underlying hypoxemia in COPD patients. By reducing hypoxia in the alveoli, pulmonary vasoconstriction is reduced. Reducing pulmonary hypertension lowers right heart afterload, and improves right heart systolic function. Oxygen also reduces hypoxemia in the blood, which reduces the risk of developing polycythemia. However, oxygen therapy has only been shown to reduce mortality in those with severe hypoxemia (PaO2 < 55mmHg); otherwise there is no mortality benefit.
Just as taking prednisone can cause side effects, reducing the dose may cause problems as well. Prednisone is not addicting like a narcotic, but many patients experience withdrawal symptoms as the dose is reduced. These often include muscle soreness, joint pain, fatigue, and depression. Know that these effects are also temporary and worth bearing to allow a cutback in your dose. If you experience any unusual symptoms as your prednisone dose is reduced, contact your doctor. It may be necessary to temporarily increase your steroid dose until you are feeling better and then taper the dose more slowly.